HER2-Positive Breast Cancer: Targeted Therapies Explained
HER2-positive breast cancer is now highly treatable with targeted therapies like trastuzumab, T-DXd, and tucatinib. Learn how these drugs work, their side effects, and why newer options are changing survival rates.
Read More